Psychofarmaca en de gz-psycholoog

Arch J J & Craske MG (2007) Implications of naturalistic use of pharmacotherapy in CBT treatment for panic disorder. Behaviour research and therapy 45: 1435–1447. doi:10.1016/j. brat.2007.01.005

Bull SA ea (2002) Discontinuation of use and switching of antidepressants: Influence of patient-physician communication. JAMA : The journal of the American Medical Association 288: 1403–1409

CB(2009) Multidisciplinaire richtlijn angststoornissen. Utrecht: Trimbosinstituut

Gorgels W (2009) Stoppen met benzodiazepinen. Huisarts & wetenschap 52 (2): 1–6

Keijsers GPJ ea (red) (2011) Protocollaire behandelingen voor volwassenen. Vierde herziene druk. Amsterdam: Boom Testpublishers

Kirsch I ea (2008) Initial severity and antidepressant benefits: A meta-analysis of data submitted tthe food and drug administration. PLoS Medicine 5(2): e45. doi:10.1371/journal.pmed.0050045

Moleman P (2008) Praktische psychofarmacologie. Houten: Prelum Uitgevers

Van Balkom AJ ea (1996) Long-term benzodiazepine use is associated with smaller treatment gain in panic disorder with agoraphobia. The journal of nervous and mental disease 184: 133–135

Watanabe N ea (2009) Combined psychotherapy plus benzodiazepines for panic disorder. Cochrane database of systematic reviews (online), (1)(1), CD005335. doi:10.1002/14651858.CD005335.pub2

Werneke U ea (2006) Antidepressants and sexual dysfunction. Acta psychiatrica scandinavica 114: 384–397. doi:10.1111/j.1600–0447.2006.00890.x